Liviawati Sutjandra - Concepedia

Author

Liviawati Sutjandra

Also Known As

L SUTJANDRA, L. Sutjandra, Liviawati Sutjandra

Publications

416

Citations

H-Index

Concepts

All Affiliations

Liviawati Sutjandra is an author at Amgen (United States) specializing in medicine, pharmacology, and cancer therapeutics.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	233
2	Pharmacology	4	4	233
3	Cancer Therapeutics	3	3	202
4	Pharmacodynamic Modeling	2	2	59
5	Biostatistics	1	1	28

Liviawati Sutjandra

Publications

298

Citations

H-Index

Page 1

	Year	Citations
Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours Leonid Gibiansky, Liviawati Sutjandra, Sameer Doshi, Clinical Pharmacokinetics OncologyMetronomic TherapyPharmacologySolid TumoursPopulation Pharmacokinetic Analysis	2012	90
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors Peiming Ma, Bingbing Yang, Yow‐Ming Wang, The Journal of Clinical Pharmacology OncologyPharmacokinetic ModelingMedicineHuman Monoclonal AntibodyColorectal Cancer	2009	84
Population pharmacokinetics of darbepoetin alfa in healthy subjects Balaji Agoram, Liviawati Sutjandra, John T. Sullivan British Journal of Clinical Pharmacology	2006	34
Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim in Animals Wojciech Krzyżański, Liviawati Sutjandra, Juan José Pérez Ruixo, Pharmaceutical Research Pharmacokinetic ModelingPharmacological StudyMedicinePhysiologyPharmacology	2012	31
Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors Sameer Doshi, Liviawati Sutjandra, Jenny Zheng, Clinical Cancer Research	2012	31
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients Jianfeng Lü, Laurent Claret, Liviawati Sutjandra, Cancer Chemotherapy and Pharmacology OncologyPharmacokinetic ModelingTumor ShrinkageMedicineRadiopharmaceutical Therapy	2010	28

Page 1